Optivar

Active Ingredient(s): Azelastine
FDA Approved: * May 22, 2000
Pharm Company: * MEDPOINTE PHARM HLC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Optivar Overview

Azelastine is a potent, second-generation, selective, histamine antagonist (histamine-H1-receptor antagonist) used as a first line therapy of mild intermittent, moderate/severe intermittent and mild persistent rhinitis (new classification system for rhinitis).[citation needed] Azelastine has been formulated both as a nasal spray and as eye drops and are available worldwide under many brand names.[1] Contents 1 Medical uses 2 Side effects 3 Pharmacokinetics ...

Read more Optivar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Azelastine

Recent Optivar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Azelastine
  • Solution: 0.05%
  • Solution/drops: 0.05%
  • Spray: 0.137 ml, 0.15%(to 0.1876mg/spray)
  • Spray, Metered: 0.125mg/spray, 0.1876mg/spray, 137mcg/actuation
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Optivar: (1 result)

Sorted by National Drug Code
  • 0037-7025 Optivar .5 mg/ml Intraocular Solution/ Drops by Meda Pharmaceuticals Inc.

Other drugs which contain Azelastine or a similar ingredient: (5 results)

Related Optivar Topics:

optivar
optivar 0.05 % drops 6ml...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA